tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Income Statement

Compare
958 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q1 2025), Xeris Pharmaceuticals's total revenue was $54.27M, an increase of 12.31% from the same quarter last year. In Q1, Xeris Pharmaceuticals's net income was $-15.74M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 163.91M$ 110.25M$ 110.25M$ 49.59M$ 20.16M
Gross Profit
$ 135.27M$ 87.61M$ 87.61M$ 36.27M$ 10.83M
Operating Expenses
$ 179.28M$ 169.55M$ 169.55M$ 151.43M$ 94.37M
Depreciation and Amortization
$ 13.16M$ 12.67M$ 1.88M$ 1.47M$ 1.08M
EBITDA
$ -23.73M$ -69.31M$ -113.67M$ -80.08M$ -117.80M
Operating Income
$ -44.01M$ -81.94M$ -81.94M$ -115.16M$ -83.55M
Other Income/Expenses
$ -19.49M$ -14.14M$ -7.57M$ -7.70M$ -3.66M
Pretax Income
$ -63.50M$ -96.08M$ -96.08M$ -122.72M$ -91.25M
Net Income
$ -62.26M$ -94.66M$ -94.66M$ -122.72M$ -91.14M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.45$ -0.70$ -1.20$ -2.88$ -3.49
Diluted EPS
$ -0.45$ -0.70$ -1.20$ -2.88$ -3.49
Weighted Average Shares Outstanding
137.67M 135.63M 79.03M 42.64M 26.11M
Weighted Average Shares Outstanding (Diluted)
137.67M 135.63M 79.03M 42.64M 26.11M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis